Secondary Logo

Institutional members access full text with Ovid®

Current status of lipid emulsions in the prevention of intestinal failure-associated liver disease

Lim, Joela,b; Oschman, Alexandrac; Curiel, Kaylaa

Current Opinion in Organ Transplantation: April 2019 - Volume 24 - Issue 2 - p 188–192
doi: 10.1097/MOT.0000000000000620
SMALL BOWEL TRANSPLANTATION: Edited by Douglas G. Farmer
Buy
SDC

Purpose of review The current review provides a summary of available lipid products and discusses current literature and the limitations to the use of various lipid products for treatment and prevention of intestinal failure-associated liver disease (IFALD) in pediatric patients dependent on parenteral nutrition.

Recent findings Improvements in markers of cholestasis and liver function have been seen with minimizing soybean lipid, fish oil lipid, and mixed fish oil-containing lipid emulsions. Soybean-based lipid products are thought to be the biggest contributor to development of IFALD. Mixed fish oil-containing lipid emulsions are most promising for minimizing and improving IFALD.

Summary Several types of lipid-based products are available for parenteral nutrition. Newer products like the mixed fish oil-containing-based lipid emulsions, that closely mimic the lipid composition provided by enteral feeding, may impact prevention and treatment of IFALD. Limitations exist in the current literature regarding mixed fish oil-containing-based emulsions, as many of the studies were designed to show efficacy with regard to growth, not prevention or treatment of IFALD. Based on available literature, it is reasonable to make some recommendations with regard to product selection for lipid provision.

aDepartment of Gastroenterology, Hepatology, and Nutrition, Children's Mercy

bDepartment of Pediatrics, School of Medicine, University of Missouri-Kansas City

cDepartment of Pharmacy, Children's Mercy, Kansas City, Missouri, USA

Correspondence to Joel Lim, 2401 Gillham Road, Kansas City, MO 64108, USA. Tel: +1 317 250 4959; e-mail: jdrlim@gmail.com

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.